Alex Marson

GenScript's First Gene & Cell Engineering Virtual Summit, Produced by Labroots, Opens July 22, 2021

Retrieved on: 
Thursday, July 15, 2021

YORBA LINDA, Calif., July 15, 2021 /PRNewswire-PRWeb/ -- The GenScript Gene & Cell Engineering Virtual Summit is being held July 22, 2021 and will feature pioneers pushing the boundaries in gene and cell engineering, providing deep expertise in gene synthesis technologies.

Key Points: 
  • YORBA LINDA, Calif., July 15, 2021 /PRNewswire-PRWeb/ -- The GenScript Gene & Cell Engineering Virtual Summit is being held July 22, 2021 and will feature pioneers pushing the boundaries in gene and cell engineering, providing deep expertise in gene synthesis technologies.
  • The GenScript Gene & Cell Engineering Virtual Summit will feature a keynote presentation by Alexander Marson, MD, Ph.D., Director, Gladstone-UCSF Institute of Genomic Immunology.
  • Produced on Labroots' robust platform, connecting across all desktop and mobile devices, the experience includes a virtual lobby, an auditorium with interactive speaker presentations, and a virtual exhibit hall for participants to explore the latest gene and cell engineering technologies.
  • GenScript is the leading contract research organization in the world, providing gene, peptide, protein, CRISPR, and antibody products and services.

The Parker Institute for Cancer Immunotherapy Appoints Seasoned Health Care Leader Frederic Pla as Chief Operating Officer

Retrieved on: 
Thursday, April 9, 2020

SAN FRANCISCO, April 9, 2020 /PRNewswire/ --The Parker Institute for Cancer Immunotherapy (PICI) announced today that Frederic Pla, Ph.D. , has been named chief operating officer (COO).

Key Points: 
  • SAN FRANCISCO, April 9, 2020 /PRNewswire/ --The Parker Institute for Cancer Immunotherapy (PICI) announced today that Frederic Pla, Ph.D. , has been named chief operating officer (COO).
  • "Frederic embodies all of the qualities we were looking for in a COO," said Sean Parker, PICI founder and chairman.
  • "My passion and strengths are building high-impact organizations in health care technologies through innovative combinations of science, technologies and business models," said Pla.
  • The Parker Institute for Cancer Immunotherapy (PICI) is radically changing the way cancer research is done.

UC Berkeley Extension, Innovative Genomics Institute Launch CRISPR Genome Editing Courses

Retrieved on: 
Tuesday, June 4, 2019

UC Berkeley Extension and the Innovative Genomics Institute (IGI) announce the launch of a practical training on CRISPR and genome editing.

Key Points: 
  • UC Berkeley Extension and the Innovative Genomics Institute (IGI) announce the launch of a practical training on CRISPR and genome editing.
  • Participants will study topics such as CRISPR immunity, genomics and sequencing technology, DNA repair, and genome editing safety and accuracy.
  • The Innovative Genomics Institute (IGI) is a non-profit, academic partnership between UC Berkeley and UC San Francisco that supports collaborative research projects across the Bay Area.
  • As pioneers in genome editing, functional genomics and other cutting-edge technologies, IGI scientists continuously push the boundaries of science.